Journal Summary - Discover more summaries and articles from M3 India - Endocrinology

Profile

Close

Journal Summaries

Endocrinology

Pharmacology/kinetics

Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study

Journal of Diabetes Investigation | Oct 02, 2017 Pharmacology/kinetics

Metformin vs sulfonylurea use and risk of dementia in US veterans aged >=65 years with diabetes

NeurologyÂ® | Oct 02, 2017 Pharmacology/kinetics

Efficacy and safety of glucagon-like peptide-1 agonists on macrovascular and microvascular events in type 2 diabetes mellitus: A meta-analysis

Nutrition, Metabolism & Cardiovascular Diseases | Evidence based | Oct 01, 2017 Pharmacology/kinetics

Insulin therapy increases cardiovascular risk: Time for a sea of change in type 2 diabetes treatment

Progress in Cardiovascular Diseases | Sep 29, 2017 Pharmacology/kinetics

The use of saxagliptin in people with type 2 diabetes in France: The Diapazon epidemiological study

Diabetes Therapy | Sep 28, 2017 Pharmacology/kinetics

Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis

Archives of Osteoporosis | Sep 27, 2017 Pharmacology/kinetics

Dose-dependent effect of sitagliptin on carotid atherosclerosis in patients with type 2 diabetes mellitus receiving insulin treatment: A post hoc analysis

Diabetes Therapy | Sep 26, 2017 Pharmacology/kinetics

Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial

Journal of Diabetes Investigation | Sep 22, 2017 Pharmacology/kinetics

Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicenter, randomized, double-blind, active-controlled, phase 3 trial

Diabetes, Obesity and Metabolism | Sep 22, 2017 Pharmacology/kinetics

Possible long-term efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, for slowly progressive type 1 diabetes (SPIDDM) in the stage of non-insulin-dependency: An open-label randomized controlled pilot trial (SPAN-S)

Diabetes Therapy | Sep 22, 2017 Pharmacology/kinetics

« Prev 1 … 115 116 117 118 119 … 122 Next »

Most read this week

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Home
Quiz
Videos
Menu

Add M3 India to your Home screen

Tap

and select "Add to Home screen" to pin the M3 India App to your Home screen

Okay